Histogen, Inc. (HSTO)
Stock Price:
$1.51 USD
-0.05 (-3.21%)
Updated November 24, 4:00 PM EST - Market closed
After-hours: $1.53 +0.02 (1.33%) Nov 24, 7:53 PM
Key Info
| Market Cap |
25.55M |
| Revenue (ttm) |
1.13M |
| Net Income (ttm) |
-19.63M |
| Shares Out |
16.92M |
| EPS (ttm) |
-3.59 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
November 24 |
| Last Price |
$1.51 |
| Previous Close |
$1.56 |
| Change ($) |
-0.05 |
| Change (%) |
-3.21% |
| Day's Open |
1.51 |
| Day's Range |
1.48 - 1.58 |
| Day's Volume |
86,526 |
| 52-Week Range |
1.30 - 7.50 |
More Stats
| Market Cap |
25.55M |
| Enterprise Value |
23.86M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
16.92M |
| Float |
14.94M |
| EPS (basic) |
-3.59 |
| EPS (diluted) |
-3.59 |
| FCF / Share |
-0.82 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
65,912 |
| Short Ratio |
1.14 |
| Short % of Float |
0.44% |
| Beta |
n/a |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
22.63 |
| PB Ratio |
3.43 |
| Revenue |
1.13M |
| Operating Income |
-19.94M |
| Net Income |
-19.63M |
| Free Cash Flow |
-10.01M |
| Net Cash |
1.69M |
| Net Cash / Share |
0.10 |
| Gross Margin |
97.36% |
| Operating Margin |
-1,766.16% |
| Profit Margin |
-1,738.40% |
| FCF Margin |
-886.71% |
| ROA |
-82.09% |
| ROE |
-338.53% |
| ROIC |
-427.00% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Forecasts
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Low
15.0
Current: $1.51
High
15.0
Target: 15.00
*Average 12-month price target from 1 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|
| Revenue | 21.72 | 33.59 | 35.38 | 0.80 | - | - | - | - | - |
| Revenue Growth | -35.34% | -5.06% | 4327.66% | - | - | - | - | - | - |
| Gross Profit | 21.72 | 33.59 | 35.38 | 0.80 | - | - | - | - | - |
| Operating Income | -12.01 | -18.28 | -17.55 | -29.83 | -24.13 | -22.29 | -11.60 | -8.61 | -12.36 |
| Net Income | -11.39 | -18.01 | -17.40 | -29.73 | -24.15 | -22.32 | -15.62 | -8.75 | -12.00 |
| Shares Outstanding | 3.32 | 3.04 | 2.86 | 2.27 | 1.86 | 1.55 | 0.74 | 0.10 | 0.10 |
| Earnings Per Share | -3.40 | -5.90 | -6.10 | -13.10 | -13.00 | -14.40 | -6.30 | -86.00 | -118.60 |
| Operating Cash Flow | -20.20 | -34.86 | -33.21 | 27.00 | -22.55 | -18.26 | -10.63 | -8.56 | -12.10 |
| Capital Expenditures | -0.01 | -0.07 | -0.03 | -0.11 | -0.09 | -0.24 | - | -0.02 | -0.02 |
| Free Cash Flow | -20.21 | -34.92 | -33.23 | 26.89 | -22.63 | -18.50 | -10.64 | -8.58 | -12.11 |
| Cash & Equivalents | 2.08 | 40.69 | 74.85 | 77.02 | 36.51 | 37.07 | 56.35 | 8.03 | 16.76 |
| Total Debt | 0.11 | - | 13.16 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Net Cash / Debt | 1.97 | 40.69 | 61.70 | 76.02 | 35.51 | 36.07 | 55.35 | 7.03 | 15.76 |
| Assets | 2.94 | 48.80 | 81.94 | 82.32 | 39.73 | 38.45 | 56.94 | 8.15 | 16.96 |
| Liabilities | 1.84 | 21.40 | 53.95 | 60.54 | 5.19 | 5.23 | 3.82 | 66.48 | 66.70 |
| Book Value | -37.07 | 27.40 | 28.00 | 21.79 | 34.54 | 33.21 | 53.12 | -58.34 | -49.74 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Histogen, Inc. |
| Country |
United States |
| Employees |
22 |
| CEO |
Richard W. Pascoe |
Stock Information
| Ticker Symbol |
HSTO |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Biotechnology |
| Unique Identifier |
NASDAQ: HSTO |
Description
Histogen, a regenerative medicine company, develops therapies based upon the products of cells grown under simulated embryonic conditions. It offers human multipotent cell conditioned media (CCM); human extracellular matrix (hECM); and hair stimulating complex (HSC). The company's technology focuses on stimulating a patient's own stem cells by delivering a complex of multipotent human proteins that support stem cell growth and differentiation. Histogen Inc. is headquartered San Diego, California.